Brief: Alimera Sciences Receives $20 Million From Ocumension Therapeutics

Alimera Sciences

14/04/2021 14:27

April 14 (Reuters) - Alimera Sciences Inc  ALIM.O :
    * ALIMERA SCIENCES RECEIVES $20 MILLION FROM OCUMENSION
THERAPEUTICS
    * ALIMERA SCIENCES - GRANTS EXCLUSIVE LICENSE TO OCUMENSION
FOR
$10 MILLION UPFRONT PAYMENT AND UP TO $89 MILLION IN ADDITIONAL
SALES-BASED MILESTONE PAYMENTS
    * ALIMERA SCIENCES INC - OCUMENSION MAKES A $10 MILLION
EQUITY
INVESTMENT IN ALIMERA
    * ALIMERA SCIENCES -  OCUMENSION THERAPEUTICS ACQUIRED AN
EXCLUSIVE LICENSE AGREEMENT FOR ALIMERA'S 0.19MG FLUOCINOLONE
ACETONIDE INTRAVITREAL IMPLANT
    * ALIMERA SCIENCES - UNDER TERMS OF SHARE PURCHASE
AGREEMENT,
OCUMENSION HAS PURCHASED 1.1 MILLION SHARES OF CO'S COMMON STOCK
AT ABOUT $8.73 PER SHARE

Source text for Eikon:  ID:nGNX1LtMSC 
Further company coverage:  ALIM.O 

 ((Reuters.Briefs@thomsonreuters.com;))